Market Place
Sourcing Support
All News #Library
Generics
Padagis Awarded New York Department of Health Naloxone Contract
12 Nov 2025 //
PR NEWSWIRE
Padagis Invests $36M+ To Expand U.S. Manufacturing
28 Oct 2025 //
PR NEWSWIRE
Padagis, The Naloxone Project Partner To Expand Naloxone Access
23 Sep 2025 //
PR NEWSWIRE
Michigan Boosts Naloxone Access with Padagis` Generic Nasal Spray
09 Jul 2025 //
PR NEWSWIRE
Padagis extends Naloxone HCl Nasal Spray shelf-life to 36 months
02 Apr 2025 //
PR NEWSWIRE
Arcutis and Padagis Agree to Stay Patent Lawsuit
02 Apr 2025 //
GLOBENEWSWIRE
Padagis Naloxone Becomes Lowest Priced Treatment on Amazon
03 Feb 2025 //
PR NEWSWIRE
Sol-Gel`s Collaboration Partner File ANDA Drug Product Generic to Zoryve® Cream
01 Apr 2024 //
GLOBENEWSWIRE
Padagis Announces First Generic OTC Approval Of A Naloxone Nasal Spray Product
19 Jul 2023 //
PR NEWSWIRE
PADAGIS ANNOUNCES TWO FIRST-TO-FILE ANDA SUBMISSIONS
15 Jun 2023 //
PR NEWSWIRE
PADAGIS ANNOUNCES FDA APPROVAL OF A-RATED GENERIC VERSION OF UCERIS
28 Apr 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.